These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12197567)

  • 1. Refractory atopic dermatitis treated with low dose cyclosporin.
    Yu FC; Gibbon GW; Klaustermeyer WB
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):127-31. PubMed ID: 12197567
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of food intake on the clinical response to cyclosporin A in canine atopic dermatitis.
    Thelen A; Mueller RS; Linek M; Peters S; Stechmann K; Steffan J
    Vet Rec; 2006 Dec; 159(25):854-6. PubMed ID: 17172483
    [No Abstract]   [Full Text] [Related]  

  • 3. Tapering cyclosporine after long-term treatment of atopic dermatitis.
    Frankel HC; Frangos JE; Qureshi AA
    J Eur Acad Dermatol Venereol; 2012 Jun; 26(6):792-3. PubMed ID: 21645125
    [No Abstract]   [Full Text] [Related]  

  • 4. A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life.
    Czech W; Bräutigam M; Weidinger G; Schöpf E
    J Am Acad Dermatol; 2000 Apr; 42(4):653-9. PubMed ID: 10727313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B.
    Campione E; Paternò EJ; Diluvio L; Bianchi L; Giorgetti G; Chimenti S
    Acta Derm Venereol; 2008; 88(1):74-5. PubMed ID: 18176762
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe atopic dermatitis treated with everolimus.
    Van Velsen SG; Haeck IM; Bruijnzeel-Koomen CA
    J Dermatolog Treat; 2009; 20(6):365-7. PubMed ID: 19954394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis.
    Berth-Jones J; Graham-Brown RA; Marks R; Camp RD; English JS; Freeman K; Holden CA; Rogers SC; Oliwiecki S; Friedmann PS; Lewis-Jones MS; Archer CB; Adriaans B; Douglas WS; Allen BR
    Br J Dermatol; 1997 Jan; 136(1):76-81. PubMed ID: 9039299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cyclosporin in atopic dermatitis].
    Pacor ML; Biasi D; Di Lorenzo G; Carletto A; Corrocher R
    Recenti Prog Med; 2001 Jun; 92(6):390-1. PubMed ID: 11433717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin A reduces CD4(+)CD25(+) regulatory T-cell numbers in patients with atopic dermatitis.
    Hijnen D; Haeck I; van Kraats AA; Nijhuis E; de Bruin-Weller MS; Bruijnzeel-Koomen CA; Knol EF
    J Allergy Clin Immunol; 2009 Oct; 124(4):856-8. PubMed ID: 19767068
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporin maintenance therapy for severe atopic dermatitis.
    Korstanje MJ; van de Staak WJ
    Acta Derm Venereol; 1991; 71(4):356-7. PubMed ID: 1681659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful cyclosporine treatment for atopic dermatitis in a rhesus macaque (Macaca mulatta).
    Ovadia S; Wilson SR; Zeiss CJ
    Comp Med; 2005 Apr; 55(2):192-6. PubMed ID: 15884783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin is safe and effective in severe atopic dermatitis of childhood. Report of three cases.
    Leonardi S; Marchese G; Rotolo N; Miraglia Del Giudice M; La Rosa M
    Minerva Pediatr; 2004 Apr; 56(2):231-7. PubMed ID: 15249910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis.
    Hijnen DJ; ten Berge O; Timmer-de Mik L; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):85-9. PubMed ID: 17207173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Cyclosporine Weekend Therapy: A New Maintenance Therapeutic Option in Patients with Severe Atopic Dermatitis.
    Garrido Colmenero C; Blasco Morente G; Tercedor Sánchez J
    Pediatr Dermatol; 2015; 32(4):551-2. PubMed ID: 25939958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis.
    Brandt C; Pavlovic V; Radbruch A; Worm M; Baumgrass R
    Allergy; 2009 Nov; 64(11):1588-96. PubMed ID: 19432936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.
    Zoller L; Ramon M; Bergman R
    Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin for atopic dermatitis in children.
    Harper JI; Berth-Jones J; Camp RD; Dillon MJ; Finlay AY; Holden CA; O'Sullivan D; Veys PA
    Dermatology; 2001; 203(1):3-6. PubMed ID: 11549791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs.
    Steffan J; Strehlau G; Maurer M; Rohlfs A
    J Vet Pharmacol Ther; 2004 Aug; 27(4):231-8. PubMed ID: 15305852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with cyclosporin A.
    Thijs JL; Drylewicz J; Bruijnzeel-Koomen CAFM; Giovannone B; Knol EF; de Bruin-Weller MS; Nierkens S; Hijnen D
    Allergy; 2019 Mar; 74(3):613-617. PubMed ID: 30368864
    [No Abstract]   [Full Text] [Related]  

  • 20. Atopic dermatitis today.
    Nevot S; Lleonart R; Casas R
    Allergol Immunopathol (Madr); 1997; 25(4):203-8. PubMed ID: 9269511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.